http://rdf.ncbi.nlm.nih.gov/pubchem/patent/MX-365096-B

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_74a7efa935f37bfb33ab80f5b0d7b0ff
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2300-00
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-593
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-1816
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-592
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-592
filingDate 2015-01-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ea88fba054fbf6fcc0bcc76ea7d6a4b3
publicationDate 2019-05-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber MX-365096-B
titleOfInvention USE OF PARICALCITOL IN THE TREATMENT OF INFLAMMATORY ANEMIA.
abstract The present invention relates to the use of paricalcitol, a synthetic vitamin D analog, in the treatment of inflammatory anemia, preferably in combination with erythropoiesis-stimulating agents. The use of paricalcitol for the treatment of this pathology is associated with a lower requirement for erythropoiesis-stimulating agents, a better use of iron, and an increase in plasma erythropoietin levels in these patients. The present invention further describes pharmaceutical compositions comprising paricalcitol in combination with erythropoiesis stimulating agents and pharmaceutically acceptable excipients, as well as the use thereof as medicaments for the treatment of inflammatory anemia.
priorityDate 2014-02-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID404002
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID13856
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ2XNF5
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP33707
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP07321
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP33708
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP33709
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID397249
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419491185
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ6H8S9
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ4T554
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ28513
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ6H8T0
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ867B1
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCA3FFS8
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ6H8T1
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID463609
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ6H8T2
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID100002479
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ6JV22
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP01588
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP29676
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP48617
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ0Z956
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426067595
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID100004455
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID2056
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID280784
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5281104
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID24335
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23925
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP49157
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP07865
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ5IGQ0
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ9GKA2

Total number of triples: 56.